Gomes da Fonseca L et al. A multicentric study on real-life impact of nivolumab in patients with hepatocellular carcinoma. (Abstract PS-137),Pinter M et al. PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: Efficacy and safety data from an international multicenter real-world cohort. (Abstract PS-138)
Bijwerkingen geen reden om te stoppen met vaccinatie, stellen hoogleraren
mei 2021 | Vaccinatie, Virale infecties